Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Dipyridamole Injection, 5 mg/mL, Apotex Corp. ANDA 75-769 11/27/02 Dipyridamole Single-Dose Vials, 5 mg/mL, 2 mL and 10 mL, American Pharmaceutical Partners ANDA 74-956 ASPIRIN; DIPYRIDAMOLE Capsule, Extended Release; 25MG;200MG AGGRENOX BOEHRINGER INGELHEIM 074601 DIPYRIDAMOLE Injection 5MG/ML DIPYRIDAMOLE Abbott 074956 DIPYRIDAMOLE Injection 5MG/ML DIPYRIDAMOLE AM PARTNERS 075769 DIPYRIDAMOLE Injection 5MG/ML DIPYRIDAMOLE Apotex 074939 DIPYRIDAMOLE Injection 5MG/ML DIPYRIDAMOLE Bedford 019817 DIPYRIDAMOLE Injection 5MG/ML IV PERSANTINE BOEHRINGER INGELHEIM 074521 DIPYRIDAMOLE Injection 5MG/ML DIPYRIDAMOLE ELKINS SINN 074952 DIPYRIDAMOLE Injection 5MG/ML DIPYRIDAMOLE Gensia Sicor 087184 DIPYRIDAMOLE Tablet; 25MG DIPYRIDAMOLE Barr 087716 DIPYRIDAMOLE Tablet; 50MG DIPYRIDAMOLE Barr 087717 DIPYRIDAMOLE Tablet; 75MG DIPYRIDAMOLE Barr 012836 DIPYRIDAMOLE Tablet; 25MG PERSANTINE BOEHRINGER INGELHEIM 012836 DIPYRIDAMOLE Tablet; 50MG PERSANTINE BOEHRINGER INGELHEIM 012836 DIPYRIDAMOLE Tablet; 75MG PERSANTINE BOEHRINGER INGELHEIM 089000 DIPYRIDAMOLE Tablet; 50MG DIPYRIDAMOLE CLONMEL 086944 DIPYRIDAMOLE Tablet; 25MG DIPYRIDAMOLE Geneva 087562 DIPYRIDAMOLE Tablet; 50MG DIPYRIDAMOLE Geneva 087561 DIPYRIDAMOLE Tablet; 75MG DIPYRIDAMOLE Geneva 089425 DIPYRIDAMOLE Tablet; 25MG DIPYRIDAMOLE Purepac 087160 DIPYRIDAMOLE Tablet; 50MG DIPYRIDAMOLE Watson Aggrenox (aspirin/extended-release dipyridamole) Capsules, Boehringer Ingelheim Pharmaceuticals Persantine (dipyridamole) Tablets, Boehringer Ingelheim, Labeling Revision | Persantine (dipyridamole USP) Tablets, Boehringer Ingelheim, Labeling Revision | Dipyridamole Tablets, Amide Pharma, Approval | Aggrenox (aspirin/extended release dipyridamole) Capsules, Boehringer Ingelheim, Labeling Revision | Dipyridamole Tablets, Murty Pharma, Approval | Aggrenox Capsules, Boehringer Ingelheim, Efficacy Supp. w/Clinical Data | Dipyridamole Tablets, Impax Labs, Approval | Dipyridamole Tablets, Zydus Pharma, Approval | Dipyridamole Tablets, Lannett, Approval ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com